Zosano Pharma Recently Implemented An Additional Workforce Reduction
T-Reuters
30 Apr 2022
Zosano Pharma Corp :Zosano Pharma Provides Corporate Update.Zosano Pharma Corp - Recently Implemented An Additional Workforce Reduction Impacting Approximately 40% Of Its Remaining Employees.Zosano Pharma Corp - In Order To Preserve Its Capital And Cash Resources, Zosano Has Suspended Its M207 Program.Zosano Pharma Corp - Suspended Gmp Manufacturing Operations At Its Fremont, California Facility.Zosano - Suspended Activities At Its Third-Party Contract Manufacturing Organizations Related To Qualification Of Commercial Manufacturing Equipment.Zosano Pharma Corp - Currently Evaluating Its Long-Lived Assets For Impairment.Zosano Pharma Corp - Remaining Feasibility Study With A Pharmaceutical Partner Is Expected To Conclude This Quarter.Zosano Pharma Corp - As Of April 26, 2022, Company Had Approximately $11.4 Million Of Cash And Cash Equivalents.Zosano Pharma - Continuing To Work With Sierraconstellation Partners As Independent Financial Advisor To Assist In Exploring Strategic Alternatives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.